AegirBio AB (AegirBio AB) Marketable Securities : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. AegirBio AB's Marketable Securities for the quarter that ended in Mar. 2024 was $0.00 Mil.

AegirBio AB Marketable Securities Historical Data

The historical data trend for AegirBio AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Marketable Securities Chart

AegirBio AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

AegirBio AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial													-	-	-	-	-

AegirBio AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

AegirBio AB (GREY:AEGBF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

AegirBio AB Marketable Securities Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

AegirBio AB (AegirBio AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

AEGIR:Sweden 52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines